Carl Zeiss Meditec Future Growth

Future criteria checks 2/6

Carl Zeiss Meditec is forecast to grow earnings and revenue by 16.3% and 7.9% per annum respectively. EPS is expected to grow by 16.7% per annum. Return on equity is forecast to be 11.9% in 3 years.

Key information

16.3%

Earnings growth rate

16.7%

EPS growth rate

Medical Equipment earnings growth14.2%
Revenue growth rate7.9%
Future return on equity11.9%
Analyst coverage

Good

Last updated15 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:AFXA - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/20272,686316238N/A6
9/30/20262,455256248N/A13
9/30/20252,275205209N/A15
9/30/20242,073162176N/A15
6/30/20242,066203N/AN/AN/A
3/31/20242,062261122263N/A
12/31/20232,094277N/AN/AN/A
9/30/20232,089290137251N/A
6/30/20232,080308N/AN/AN/A
3/31/20232,02227863162N/A
12/31/20221,963307N/AN/AN/A
9/30/20221,903294106188N/A
6/30/20221,781245N/AN/AN/A
3/31/20221,735264207285N/A
12/31/20211,688228N/AN/AN/A
9/30/20211,647236297363N/A
6/30/20211,566235N/AN/AN/A
3/31/20211,388159240290N/A
12/31/20201,335130N/AN/AN/A
9/30/20201,335122134179N/A
6/30/20201,400120N/AN/AN/A
3/31/20201,507166132171N/A
12/31/20191,505170N/AN/AN/A
9/30/20191,459160173220N/A
6/30/20191,382153N/AN/AN/A
3/31/20191,334129195242N/A
12/31/20181,310127N/AN/AN/A
9/30/20181,281126152187N/A
6/30/20181,251124N/AN/AN/A
3/31/20181,216129N/A56N/A
12/31/20171,205132N/AN/AN/A
9/30/20171,190134N/A38N/A
6/30/20171,154123N/AN/AN/A
3/31/20171,135112N/A85N/A
12/31/20161,106113N/AN/AN/A
9/30/20161,08898N/A112N/A
6/30/20161,09078N/A132N/A
3/31/20161,08380N/A96N/A
12/31/20151,06261N/A73N/A
9/30/20151,04062N/A57N/A
6/30/201598470N/A34N/A
3/31/201594666N/A44N/A
12/31/201493873N/A60N/A
9/30/201490975N/A63N/A
6/30/201493183N/A74N/A
3/31/201492489N/A69N/A
12/31/201390089N/A52N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: AFXA's forecast earnings growth (16.3% per year) is above the savings rate (1%).

Earnings vs Market: AFXA's earnings (16.3% per year) are forecast to grow slower than the German market (20.9% per year).

High Growth Earnings: AFXA's earnings are forecast to grow, but not significantly.

Revenue vs Market: AFXA's revenue (7.9% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: AFXA's revenue (7.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: AFXA's Return on Equity is forecast to be low in 3 years time (11.9%).


Discover growth companies